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COX-2 inhibitors Lumiracoxib and Celecoxib, because these
anti-inﬂammatory drugs increase the expression of collagens
types III and IV.
Methods: We evaluated in situ the presence of some
granuloma components such as collagen as well as of its
degradation product hydroxiprline. We also determined the
local presence of relevant cytokines to granuloma formation
and maintainance (TNF-, TGB-,  - IFN, GM-CSF and IL-12)
and also of NO, Pb with preserved or altered morphology and
the overall architecture of the granulomas.
Results: The best indicators of control of PCM as
expressed by successful local Pb lysis were the presence of
compact granulomas, delimited by a continuous deposit of
collagen type 1 arranged in concentric orientation required
to contain the fungi, and the production of high concen-
tration of cytokines IL-12 and -IFN as well as of NO. The
concentration of collagen metabolite per se was not an indi-
cator of Pb containment or dissemination.
Conclusion: Based on these parameters, we can con-
clude that therapy with -IFN and /or Tetracycline seems
promising, reducing the fungal load, increasing the produc-
tion of NO and of the stimulatory cytokines -IFN and IL-12,
decreasing that of the inhibitory cytokine TGB- and altering
the granulomas architecture towards a compact structure in
order to provide Pb containment without excessive ﬁbrosis.
doi:10.1016/j.ijid.2010.02.1756
30.016
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Background: Candidiasis is a nosocomial infection associ-
ated to considerable mortality and high economic impact.
The echinocandins are a new class of therapeutic medica-
tions that have shown to be effective in treating candidemia
and other forms of invasive candidiasis; however, cost of
amphotericin B dose is lower. Hypothesis: Is anidulafun-
gin (ANI) costeffective compared to caspofungin (CAS), and
amphotericin B (AMB) in the treatment of invasive candidia-
sis in non-neutropenic patients hospitalized in Intensive Care
Units (ICU) when the ﬂuconazole is not a choice, from a
third-party payer perspective.
Methods: A decision tree was designed to assess the
cost-effectiveness of the three medications and this was
validated by 2 critical care specialists and 2 infectologist.
The model simulated costs and effectiveness in a 14-week-
period. Effectiveness measure was the rate of survival and
the main outcome was saved Life Years (LYs). Clinical efﬁ-
cacy and node probabilities were obtained from a published
meta-analysis that was identiﬁed by systematic literature
review. This study estimated the direct costs associated with
invasive candidiasis treatment including antifungal drugs,
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ospitalization, and costs associated with adverse events.
edical costs were extracted from 7 ICUs of 3 major cities
nd drug costs were taken from a standard colombian cost-
ng source. The incremental cost per successfully treated
atient was calculated and the one way sensitivity analysis
as performed.
Results: Patients treated with ANI experienced the higher
utcomes (13.7 LYs) followed by AMB (12.1 LYs) and CAS (11.7
Ys). Mean cost per patient was lower with AMB (US$4,131)
ollowed by ANI (US$6,001) and CAS (US$6,444). Based on
CERs, ANI was the dominant therapy compared to CAS and
NI was cost-effective compared to AMB (ICER US$1.228).
Conclusion: Anidulafungin represents the cost-effective
reatment of choice when compared to caspofungin and
mphotericin B for the invasive candidiasis in Non-
eutropenic patients in Colombia.
oi:10.1016/j.ijid.2010.02.1757
0.017
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. Shahzad1,∗, B. Nseir2
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Ochsner Clinic Foundation, New Orleans, LA, USA
Background: Patient presented with ST elevation MI and
ied secondary to multiorgan failure. Autopsy revealed
ngioinvasive aspergillosis involving several organs.
Methods: Case: A 47-year-old African American male with
ast medical history of alcoholinduced cirrhosis presented
ith acute midsternal pain of 5 hours duration. Respiratory
istress developed and mechanical ventilation was required
or airways protection.
Results: Initial work up showed markedly elevated car-
iac enzymes with CPK 14000 U/L, elevated AST 800
/L, ALT 210 U/L, total bilirubin 8mg/dL, direct biliru-
in 7mg/dL, and ST segment elevation on inferior EKG
eads. Patient underwent emergent left heart catheteriza-
ion which revealed patent coronary arteries. Subsequently
ultiorgan failure resulted in decompensated shock and
atient received several vasopressors. Blood, spinal ﬂuid,
rine and sputum cultures showed no growth. Patient had
egative serology for HIV, acute viral hepatitis, syphilis,
engue fever, tularemia, herpes virus 1&2, CMV, EBV,
eptospirosis, Q fever, Lyme disease, brucellosis, and
hrlichiosis. Patient experienced intractable ventricular ﬁb-
illation which resulted in death after a 13-day hospital
tay. Autopsy report conﬁrmed disseminated angioinvasive
spergillosis involving heart, lungs, bowel, thyroid, kidneys
nd spleen in addition to complete occlusion of the poste-
ior descending artery with a fungal thrombus and multiple
ungal vegetations.
Conclusion: Discussion: Aspergillus organisms are ubiq-
itous and exposure to their conidia must be a frequent
vent. However, disease due to tissue invasion is uncommon
nd occurs primarily in the setting of immunosuppression.
isk factors for invasive aspergillosis include prolonged and
evere neutropenia, organ transplantation, AIDS and corti-
osteroid use.
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dida albicans remained the most common isolated specie.
Mortality was statistically signiﬁcant related to persistent
candidemia and the delay to remove CVC.124 14
Infection of virtually any organ can occur, but most com-
only kidney, liver, spleen, and CNS are involved. Aspergillus
s second only to Candida as a cause of fungal endocarditis.
Patients typically present with fever and embolic phe-
omena. Blood cultures are rarely positive. Prognosis of
spergillus endocarditis is poor. Even with combinedmedical
nd surgical therapy, the mortality approaches 100 percent.
eptic embolization has been occasionally reported as a rea-
on for cerebral, myocardial and pulmonary infarctions. Our
eport represents rare case of myocardial infarction as a part
f aspergillus septic emboli in the setting of hepatic cirrho-
is as etiology of the immunocompromised state. Autopsy;
owever could not identify the original infected source.
oi:10.1016/j.ijid.2010.02.1758
0.018
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Background: In vitro studies demonstrated that a clini-
ally relevant concentration of cryptococcal polysaccharide
nhanced HIV-1 production in peripheral mononuclear
ells (Pettoello-Mantovani M, et al. Enhancement of HIV-
infection by the capsular polysaccharide of Cryptococcus
eoformans. Lancet 1992, 339:21-23). However, the corre-
ation between cryptococcal capsular polysaccharide (CCP)
oncentrations and HIV-1 viral load has never been assessed
n a clinical setting. Considering the immunomodulatory
roperties of CCP and that extrapulmonary cryptococco-
is is one of the most frequent HIV-related opportunistic
nfections in our region, the evaluation of potential patho-
hysiological interactions between these pathogens are of
mportance for development of therapeutic strategies.
Methods: Prospective collection of pretreatment blood
amples from antiretroviral naive HIVinfected patients with
ulture-conﬁrmed cryptococcal meningitis assisted at the
nfectious Diseases Hospital ‘‘Francisco Javier Mun˜iz’’,
uenos Aires, Argentina (period 2004-2006).
Informed consent was obtained from all patients. HIV
lasma viral load was measured by reverse transcriptase-
olymerase chain reaction using the Cobas Amplicor HIV-1
onitor Test 1.5 (Roche). CCP antigen concentration
as determined by a standard commercial assay (Latex-
ryptococcus Antigen Detection System-IMMY, Immunomy-
ologics). A linear regression analysis was performed with
tatistix 7.0 software. Florencio Fiorini ‘‘Estimulo’’ Schol-
rship by Florencio Fiorini Foundation and by Asociacion
edica Argentina was obtained for the development of the
tudy, as part of an investigation of HIV-1 related cryptococ-
osis.
Results: During the study, 37 HIV-infected patients with
ryptococcal meningitis were enrolled. Data regarding HIV-1
lasma viral load and CCP concentrations were available for
5 patients for the ﬁnal analysis. Median HIV plasma con-
entration (copies/mL) was 296000 (range: 1000-750000).
edian serum CCP antigen titer was 100 (range: 0-10000).
dternational Congress on Infectious Diseases (ICID) Abstracts
inear regression analysis found no evidence of a statistical
igniﬁcant correlation between HIV-1 plasma viral load and
CP concentrations (r = 0.1522; p = 0.4676).
Conclusion: In opposition to in vitro ﬁndings, HIV-1
lasma viral load has no correlation with CCP concentra-
ions. To the best of our knowledge, this is the ﬁrst study
o assess if there is a relationship between the levels of an
pportunistic pathogen in blood and HIV-1 viral load in a real
ife clinical setting.
oi:10.1016/j.ijid.2010.02.1759
0.019
isk factors for candidemia-related mortality in a Neona-
al Intensive Care Unit (NICU)
.I. Echave ∗, M.L. Praino, M.L. Vozza, C. Manso, M.
ussman, C. Enfedaque, A. Martinez Burkett, A. Procopio,
. Rivas, E.L. Lopez
Hospital de Nin˜os Ricardo Gutiérrez, Buenos Aires,
rgentina
Background: Candidemia is related to signiﬁcant morbid-
ty and mortality, specially in infants at the NICU. The aim
f this study was to identify the risk factors for mortality
mong these patients
Methods: We retrospectively studied all the patients with
ositive blood cultures for Candida spp. treated in NICU
etween, January 2003 and December 2008, at the Hospital
e Nin˜os ‘‘Ricardo Gutierrez’’ in Buenos Aires, Argentina.
e analyzed the clinical baseline characteristics and risk
actors for mortality: persistence of positive blood cultures,
ays to central venous catheter (CVC) removal, underly-
ng diseases, secondary compromised organs and species of
andida.
Results: During the study period a total of 20 patients
ere identiﬁed. However, 2 patients were excluded, due
o insufﬁcient data in the medical records. Ten patients
ere male (55%); age: median 40 days (range 7-117 ds).
ll patients were admitted to the NICU, immediately after
irth. None of them was less than 28 weeks gestation. The
eight at birth was less than 1500 g in only one patient. The
ost frequent underlying disease was surgical pathology of
he gastrointestinal tract (9/18, 50%). Most of the patients
ad risk factors for candidemia as CVC (14/18, 77,7%), par-
nteral nutrition (15/18, 83%) and previous use of broad
pectrum antibiotics (100%). Candida albicans resulted the
ain agent (9/19, 47%). One patient had two different
pecies of Candida: albicans and tropicalis. The global mor-
ality rate was 27.7% (5/18). Mortality was associated with:
ater removal of catheter, mean 1.9 ds vs. 5.8ds, (p = 0.02)
nd days to ﬁrst negative blood culture: mean 4.36 ds vs. 9
s (p = 0.025), in survivors vs patients who died, respectively.
Conclusion: The high mortality rate by Candida in our
etting was similar to the reported by the literature. Can-oi:10.1016/j.ijid.2010.02.1760
